Key result
High CHA2DS2-VASc-HSF score linked to ~70 percentage point higher multivessel disease rate in STEMI.
Why the study?
The severity and outcomes of coronary artery disease may be more accurately predicted by the CHA2DS2-VASc-HSF score incorporating additional cardiovascular risk factors in STEMI patients undergoing primary PCI.
Does a high CHA2DS2-VASc-HSF score predict greater coronary artery disease severity in STEMI patients undergoing primary PCI?
Observational (n=200)
Does a high CHA2DS2-VASc-HSF score predict greater coronary artery disease severity in STEMI patients undergoing primary PCI?
Absolute Event Rate: 74.07% vs 4.35%
p-value: p=<0.0001
The CHA2DS2-VASc-HSF score effectively stratifies STEMI patients by angiographic severity of coronary artery disease prior to primary PCI.
High CHA2DS2-VASc-HSF score associated with multivessel disease in STEMI; hypothesis-generating and requires prospective validation before clinical use.
Background and aim The severity and outcomes of coronary artery disease could be associated with additional cardiovascular risk factors, and can be more accurately predicted by the congestive heart failure, hypertension, age ≥ 75 years (2 points), diabetes mellitus, prior Stroke/transient ischemic attack/thromboembolism (2 points), Vascular disease, Age 65–74 years, Sex category (female), Hyperlipidemia, Smoking, and Family history (CHA 2 DS 2 -VASc-HSF) score. This study aimed to assess the severity of coronary artery disease by linking the short-term clinical outcomes of patients with ST-segment elevation myocardial infarction (STEMI) treated with primary Percutaneous Coronary Intervention to the CHA 2 DS 2 -VASc-HSF Score. Patients and methods This study was carried out on 200 adult patients greater than 40 years old who had acute STEMI and were candidates for primary Percutaneous Coronary Intervention. All patients were allocated into two groups depending on the CHA 2 DS 2 -VASc-HSF score: the first group (1) ( n =92) had a CHA 2 DS 2 -VASc-HSF score less than 4, and the second group (2) ( n =108) had a CHA 2 DS 2 -VASc-HSF score more than 4. Results In group 1 (low-score), single-vessel disease was most frequent (78.26%), compared with only 3.70% in group 2 (high-score) ( P <0.0001). Double-vessel disease occurred in 17.39% of group 1 and 22.22% of group 2 ( P =0.500). Notably, involvement of more than two vessels was markedly more common in group 2 (high-score group) (74.07%) versus the low-score group 1 (4.35%) ( P <0.0001). Conclusion The CHA 2 DS 2 -VASc-HSF score effectively stratifies STEMI patients into distinct risk groups with significantly different cardiovascular risk factor profiles.
No takes yet. Share an insight, caveat, or question.
Abd-Rabbo et al. (2026) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=200). High CHA2DS2-VASc-HSF score (>4) vs. Low CHA2DS2-VASc-HSF score (<4) was evaluated on Involvement of more than two vessels (p=<0.0001). A high CHA2DS2-VASc-HSF score (>4) was strongly associated with having more than two involved coronary vessels (74.07% vs 4.35%) compared to a low score in STEMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: